AU2001231931A1 - Use of modafinil for making a medicine for correcting disorders affecting vigilance related to myopathies - Google Patents
Use of modafinil for making a medicine for correcting disorders affecting vigilance related to myopathiesInfo
- Publication number
- AU2001231931A1 AU2001231931A1 AU2001231931A AU3193101A AU2001231931A1 AU 2001231931 A1 AU2001231931 A1 AU 2001231931A1 AU 2001231931 A AU2001231931 A AU 2001231931A AU 3193101 A AU3193101 A AU 3193101A AU 2001231931 A1 AU2001231931 A1 AU 2001231931A1
- Authority
- AU
- Australia
- Prior art keywords
- modafinil
- myopathies
- vigilance
- medicine
- making
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 title abstract 2
- 208000021642 Muscular disease Diseases 0.000 title abstract 2
- 201000009623 Myopathy Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229960001165 modafinil Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0001211A FR2804322B1 (fr) | 2000-01-31 | 2000-01-31 | Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies |
| FR0001211 | 2000-01-31 | ||
| PCT/FR2001/000271 WO2001054648A2 (fr) | 2000-01-31 | 2001-01-29 | Traitement des troubles de la vigilance associes aux myopathies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001231931A1 true AU2001231931A1 (en) | 2001-08-07 |
Family
ID=8846505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001231931A Abandoned AU2001231931A1 (en) | 2000-01-31 | 2001-01-29 | Use of modafinil for making a medicine for correcting disorders affecting vigilance related to myopathies |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6462089B1 (tr) |
| EP (1) | EP1251842B1 (tr) |
| JP (2) | JP2003521487A (tr) |
| AT (1) | ATE247956T1 (tr) |
| AU (1) | AU2001231931A1 (tr) |
| DE (1) | DE60100660T2 (tr) |
| DK (1) | DK1251842T3 (tr) |
| ES (1) | ES2206400T3 (tr) |
| FR (1) | FR2804322B1 (tr) |
| MX (1) | MXPA02007236A (tr) |
| PT (1) | PT1251842E (tr) |
| TR (1) | TR200300575T3 (tr) |
| WO (1) | WO2001054648A2 (tr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ524359A (en) * | 2000-07-27 | 2005-06-24 | Teva Pharma | Crystalline and pure modafinil, and process of preparing the same |
| US20040048931A1 (en) * | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
| US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| US20040116532A1 (en) * | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
| US20040253308A1 (en) * | 2003-04-29 | 2004-12-16 | Barr Laboratories, Inc. | Surface-treated modafinil particles |
| EA009949B1 (ru) * | 2004-02-06 | 2008-04-28 | Сефалон, Инк. | Композиции модафинила |
| CN100343228C (zh) * | 2006-02-17 | 2007-10-17 | 中国科学院上海有机化学研究所 | 高对映体选择性制备 2－二苯甲基亚磺酰基－乙酰胺单一对映体的方法 |
| WO2008003093A2 (en) * | 2006-06-29 | 2008-01-03 | Questcor Pharmaceuticals, Inc. | Pharmaceutical compositions and related methods of treatment |
| US20080181966A1 (en) * | 2006-10-18 | 2008-07-31 | Cephalon, Inc. | Modafinil pharmaceutical compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1584462A (en) * | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
| FR2593809B1 (fr) * | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
| US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
| FR2771004B1 (fr) * | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
| US6346548B1 (en) * | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
-
2000
- 2000-01-31 FR FR0001211A patent/FR2804322B1/fr not_active Expired - Fee Related
- 2000-06-29 US US09/606,238 patent/US6462089B1/en not_active Expired - Lifetime
-
2001
- 2001-01-29 JP JP2001555628A patent/JP2003521487A/ja active Pending
- 2001-01-29 PT PT01903990T patent/PT1251842E/pt unknown
- 2001-01-29 EP EP01903990A patent/EP1251842B1/fr not_active Expired - Lifetime
- 2001-01-29 MX MXPA02007236A patent/MXPA02007236A/es active IP Right Grant
- 2001-01-29 DK DK01903990T patent/DK1251842T3/da active
- 2001-01-29 AT AT01903990T patent/ATE247956T1/de active
- 2001-01-29 WO PCT/FR2001/000271 patent/WO2001054648A2/fr active IP Right Grant
- 2001-01-29 ES ES01903990T patent/ES2206400T3/es not_active Expired - Lifetime
- 2001-01-29 DE DE60100660T patent/DE60100660T2/de not_active Expired - Lifetime
- 2001-01-29 AU AU2001231931A patent/AU2001231931A1/en not_active Abandoned
- 2001-01-29 TR TR2003/00575T patent/TR200300575T3/tr unknown
-
2012
- 2012-06-14 JP JP2012134680A patent/JP2012197304A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ATE247956T1 (de) | 2003-09-15 |
| FR2804322B1 (fr) | 2002-04-19 |
| PT1251842E (pt) | 2004-01-30 |
| TR200300575T3 (tr) | 2003-06-23 |
| ES2206400T3 (es) | 2004-05-16 |
| EP1251842A2 (fr) | 2002-10-30 |
| FR2804322A1 (fr) | 2001-08-03 |
| JP2003521487A (ja) | 2003-07-15 |
| DE60100660D1 (de) | 2003-10-02 |
| WO2001054648A3 (fr) | 2002-06-06 |
| DK1251842T3 (da) | 2003-12-22 |
| EP1251842B1 (fr) | 2003-08-27 |
| DE60100660T2 (de) | 2004-02-26 |
| MXPA02007236A (es) | 2003-09-05 |
| JP2012197304A (ja) | 2012-10-18 |
| WO2001054648A2 (fr) | 2001-08-02 |
| US6462089B1 (en) | 2002-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1044282A1 (zh) | 作為趨化因子受體活性調節劑的n-脲基烷基-哌啶化合物 | |
| MXPA02012712A (es) | N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas. | |
| HK1066790A1 (en) | Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes | |
| PL338352A1 (en) | Derivatives of 1-(n-phenylaminoalkyl)-piperazine substituted at position 2 of its phenyl ring | |
| PL370381A1 (en) | Substituted piperazines as modulators of the melanocortin receptor | |
| AU2002220715A1 (en) | Indolsulfonyl compounds useful in the treatment of cns disorders | |
| HU9602229D0 (en) | Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace | |
| WO2001098268A3 (en) | Piperidine amides as modulators of chemokine receptor activity | |
| AU4531001A (en) | Compounds with 5-HT<sub>1A</sub> activity useful for treating disorders of the outer retina | |
| AU2001231931A1 (en) | Use of modafinil for making a medicine for correcting disorders affecting vigilance related to myopathies | |
| AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
| TW324662B (en) | Benzamide-containing pharmaceutical composition | |
| PT1404304E (pt) | Comprimido contendo cetirizina e pseudoefedrina | |
| AU2003272767A1 (en) | Use of tricyclic amides for the treatment of disorders of calcium homeostasis | |
| WO2001098270A3 (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
| AU4179399A (en) | Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders | |
| WO2001098269A3 (en) | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity | |
| MY129643A (en) | Tablet comprising cetirizine and pseudoephedrine | |
| AU9157698A (en) | Piperazine derivatives active on the lower urinary tract | |
| WO2002096855A3 (en) | Anticholinergic compounds and methods of use | |
| AU2002221077A1 (en) | Arc electrodes for synthesis of carbon nanostructures | |
| IL158186A0 (en) | Pharmaceutically active compounds and methods of use | |
| AU2002365288A1 (en) | Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases | |
| TNSN05154A1 (en) | Use of levocetirizine for the treatment of persistent allergic rhinitis | |
| MXPA03006816A (es) | Uso de 2-amino-1-84-hidroxi-3-metanosulfonamidofenil) etanol para tratar la incontinencia urinaria. |